Delivery Order SPE2DB24D1201-SPE2DB25FJECE
- Not listed
- The Defense Logistics Agency awarded a $1,051.80 firm fixed price delivery order to AmerisourceBergen Drug Corp for XYOSTED 100 mg/0.5 mL auto-injector (0.5 mL), with an ultimate completion date of November 10, 2025. This non-set-aside competitive award was issued on November 7, 2025, with performance to be executed at AmerisourceBergen's Conshohocken, Pennsylvania facility. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with...
- The Defense Logistics Agency awarded a delivery order valued at $2,121.33 to AmerisourceBergen Drug Corp for the supply of Xyosted 75 mg/0.5 ml auto-injector units on November 18, 2025, with completion targeted for November 19, 2025. This is a firm fixed-price delivery order with no set-aside designation, issued under a competitive procurement process. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $1,936.96 delivery order on July 23, 2025, for XYOSTED 75 mg/0.5 mL auto-injector units (0.5 mL). This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of July 24, 2025. The performance location is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order represents a child contract under the company's larger pharmaceutical supply...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for XYOSTED 75 mg/0.5 ml auto-injector supplies, valued at $1,006.78 under a firm fixed-price arrangement. The award, issued on June 30, 2025, with an ultimate completion date of July 1, 2025, represents a non-competitive delivery order. Performance will be executed at the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a $4,435.37 firm fixed-price delivery order to AmerisourceBergen Drug Corp on October 28, 2025, for the supply of XYOSTED 75 mg/0.5 mL auto-injector units. The contract, which was competitively awarded with no set-aside designation, has an ultimate completion date of October 29, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for XYOSTED 75 MG/0.5 ML auto-injector supplies valued at $5,675.20 on December 3, 2025, with completion expected by December 4, 2025. This competitively awarded, firm fixed price delivery order represents AmerisourceBergen's continued role as a critical pharmaceutical supplier to federal medical procurement needs. The contract is not set-aside and performs out of the vendor's corporate office location in...
- The Defense Logistics Agency awarded a $3,302.77 delivery order to AmerisourceBergen Drug Corp for XYOSTED 75 mg/0.5 ml auto-injector units on April 25, 2025, with completion targeted for April 28, 2025. This competitively awarded, firm fixed-price contract is classified as a non-set-aside procurement and represents a continuation of AmerisourceBergen's pharmaceutical supply role within the federal medical procurement system. The place of performance is located in Conshohocken, Pennsylvania,...
- The Defense Logistics Agency awarded a $2,366.55 delivery order to AmerisourceBergen Drug Corp for XYOSTED 75 mg/0.5 mL auto-injector supplies on October 31, 2025, with completion targeted for November 3, 2025. This is a firm fixed-price delivery order with no set-aside designation, indicating competitive award. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $1,204.42 to AmerisourceBergen Drug Corp for XYOSTED 75 mg/0.5 ml auto-injector units on July 21, 2025, with completion scheduled for July 22, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. XYOSTED is a testosterone replacement therapy medication delivered via auto-injector,...
- The Defense Logistics Agency awarded a delivery order valued at $3,511.69 to AmerisourceBergen Drug Corp for XYOSTED 75 mg/0.5 ml auto-injector units on September 23, 2025, with an ultimate completion date of September 24, 2025. This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The...
- SPE2DB24D1201Indefinite Delivery Contract
- SPE2DB24D1201-SPE2DB25FJECEDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $2,149.65 to AmerisourceBergen Drug Corp for XYOSTED 75 mg/0.5 mL auto-injector units on September 5, 2025, with a completion date of September 8, 2025. This is a firm fixed price, competitively awarded delivery order with no set-aside designation, issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), an enterprise-wide pharmaceutical prime vendor vehicle valued at $999,999,999.00 through December 2026. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical supplier to federal medical procurement, particularly supporting military and veteran healthcare systems through its extensive portfolio of medications and medical supplies. This delivery order for XYOSTED, a testosterone replacement therapy auto-injector, represents a routine pharmaceutical procurement under the company's comprehensive global pharmaceutical support vehicle, which enables the supply of specialty medications, generic drugs, vaccines, and medical supplies to the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.1k | 9/5/25 |